AstraZeneca Pharma India informs about updates

28 Mar 2025 Evaluate

AstraZeneca Pharma India has informed that the company will be discontinuing with the manufacturing and marketing of the product Prolonged release Isosorbide-5-mononitrate Tablets BP 30 mg and 60 mg (Imdur) from April 1, 2025. Imdur is currently being indicated for Prophylactic treatment of angina pectoris.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

7889.20 -202.80 (-2.51%)
04-Apr-2025 12:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1708.30
Dr. Reddys Lab 1104.95
Cipla 1421.95
Lupin 1979.20
Zydus Lifesciences 868.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...